SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-201485
Filing Date
2014-05-15
Accepted
2014-05-15 17:21:50
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d712273d10q.htm 10-Q 529759
2 EX-10.2 d712273dex102.htm EX-10.2 10925
3 EX-31.1 d712273dex311.htm EX-31.1 7972
4 EX-31.2 d712273dex312.htm EX-31.2 7968
5 EX-32.1 d712273dex321.htm EX-32.1 2923
6 EX-32.2 d712273dex322.htm EX-32.2 2933
  Complete submission text file 0001193125-14-201485.txt   6204289

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT petx-20140331.xml EX-101.INS 761084
8 XBRL TAXONOMY EXTENSION SCHEMA petx-20140331.xsd EX-101.SCH 74183
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE petx-20140331_cal.xml EX-101.CAL 106418
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE petx-20140331_def.xml EX-101.DEF 263328
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE petx-20140331_lab.xml EX-101.LAB 531034
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE petx-20140331_pre.xml EX-101.PRE 411109
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 14848993
SIC: 2834 Pharmaceutical Preparations